The idea of diagnosing Alzheimer’s with a quick, finger-prick test marks a profound shift in how we could approach ...

The Guillain-Barre Syndrome Diagnostics Market is driven by the rising incidence of infections like Zika and aging populations, necessitating advanced diagnostics such as electromyography and nerve ...

Researchers found that blood samples collected at home and mailed in can reliably track early Alzheimer’s-related brain ...

Indias first AI-integrated blood biomarker test with PET and MRI imaging shows promises with early Alzheimers detection, ...

In a groundbreaking development for Alzheimer’s research, a pioneering trial has begun to assess whether a simple finger-prick blood test could provide an early diagnosis for the disease, potentially ...

A cyber insurance risk assessment finds the systems and assets most at risk of cyberattack. Learn about cyber insurance and how risk assessments work.

A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...

A collaborative research team has developed the world's first AI-based optical diagnostic platform that enables rapid and ...

Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, ...

The field of blood-based biomarkers is abuzz with possibility. Ultra-sensitive tests are able to quantify previously undetectable molecules, requiring only a vial of blood. The potential for ...

Effective protection comes from combining both approaches: aligning IT and business processes and conducting regular system ...